All Stories

  1. The Potential of Collagen Treatment for Comorbid Diseases
  2. Tolerance limits for mixture‐of‐normal distributions with application to COVID‐19 data
  3. Biomaterials in Medical Applications
  4. The Human Pre-miRNA Distance Distribution for Exploring Disease Association
  5. microRNA pathological mechanisms between Parkinson's disease, Alzheimer's disease, glaucoma and macular degeneration
  6. The distance distribution of human microRNAs in MirGeneDB database
  7. Phylogenetic Tree Selection by Testing Substitution Number in Clade
  8. Exploring the Causal Effect of Constipation on Parkinson’s Disease Through Mediation Analysis of Microbial Data
  9. A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson’s Disease
  10. COVID−19, Anti-NMDA Receptor Encephalitis and MicroRNA
  11. microRNA Biomarkers in Clinical Study
  12. Multiple imputation confidence intervals for the mean of the discrete distributions for incomplete data
  13. A Review of the Effects of Collagen Treatment in Clinical Studies
  14. The Association between Migraine and Depression based on miRNA Biomarkers and Cohort Studies
  15. MicroRNAs, Multiple Sclerosis, and Depression
  16. Editorial: miRNAs and Neurological Diseases
  17. MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
  18. Confidence intervals for the proportion of conformance
  19. Exploring the Association of Autism Spectrum Disorders and Constipation through Analysis of the Gut Microbiome
  20. Phylogenetic analysis of microRNA biomarkers for amyotrophic lateral sclerosis
  21. The Generalized Bayes Method for High-Dimensional Data Recognition with Applications to Audio Signal Recognition
  22. MicroRNA, Diabetes Mellitus and Colorectal Cancer
  23. The Association between Depression and Gastroesophageal Reflux based on Phylogenetic Analysis of miRNA Biomarkers
  24. <p>Exploring Diversity of COVID‑19 Based on Substitution Distance</p>
  25. Monitoring Change Points by a Sign Change Method
  26. MicroRNAs and Apoptosis in Colorectal Cancer
  27. Constructing exact tolerance intervals for the exponential distribution based on record values
  28. Anti-NMDA Receptor Encephalitis: Efficacy of Treatment for Male Patients and miRNA Biomarker
  29. Logistic Regression Method for Ligand Discovery
  30. Exact two‐sided tolerance interval controlling tail proportions for sample variances
  31. Anti-NMDA Receptor Encephalitis, Vaccination and Virus
  32. Vaccines and Neurological Disease
  33. Phylogenetic Analysis to Explore the Association Between Anti-NMDA Receptor Encephalitis and Tumors Based on microRNA Biomarkers
  34. Tolerance interval for the mixture normal distribution
  35. Exploring MicroRNA Biomarkers for Parkinson’s Disease from mRNA Expression Profiles
  36. How can we identify Amyotrophic Lateral Sclerosis with blood test?
  37. A protocol for investigating the association of vaccination and anti-NMDA receptor encephalitis
  38. Constructing Tolerance Intervals for the Number of Defectives Using Both High- and Low-Resolution Data
  39. Why ALS is often associated with cancers?
  40. A control chart for the lognormal standard deviation
  41. Anti-NMDA Receptor Encephalitis and Vaccination
  42. Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis
  43. On the monitoring of mixture simple linear profiles
  44. Efficacies of treatments for anti-NMDA receptor encephalitis
  45. Corrigendum to “Variance estimation for nucleotide substitution models” [Mol. Phylogenet. Evol. 90 (2015) 97–103]
  46. Multivariate control charts based on the James–Stein estimator
  47. Variance estimation for nucleotide substitution models
  48. Control Charts for the Lognormal Mean
  49. Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue
  50. Correction: Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  51. Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  52. Shrinkage regression-based methods for microarray missing value imputation
  53. RRSM with a data-dependent threshold for miRNA target prediction
  54. Bayesian Ranking Responses in Multiple-Response Questions
  55. Protein-specific Scoring Method for Ligand Discovery
  56. Confidence intervals for a bounded mean in exponential families
  57. Phylogenetic tree selection by the adjustedk-means approach
  58. Human microRNA target identification by RRSM
  59. Yeast cell cycle transcription factors identification by variable selection criteria
  60. Confidence intervals for the substitution number in the nucleotide substitution models
  61. Constructing Biological Pathways by a Two-Step Counting Approach
  62. Approximate Tolerance Limits Under Log-Location-Scale Regression Models in the Presence of Censoring
  63. Closed Form Prediction Intervals Applied for Disease Counts
  64. The monotone boundary property and the full coverage property of confidence intervals for a binomial proportion
  65. Comparison of control charts for low defective rate
  66. Increasing MicroRNA target prediction confidence by the relative R2 method
  67. Tolerance Intervals With Improved Coverage Probabilities for Binomial and Poisson Variables
  68. Improved variance estimators for one- and two-parameter models of nucleotide substitution
  69. Confidence intervals for the mean of a normal distribution with restricted parameter space
  70. Coverage probability of prediction intervals for discrete random variables
  71. Exact average coverage probabilities and confidence coefficients of confidence intervals for discrete distributions
  72. Exact confidence coefficients of simultaneous confidence intervals for multinomial proportions
  73. Ranking responses in multiple-choice questions
  74. ϵ-Admissible Estimators for Normal and Poisson Means
  75. Estimation of the Probability of Passing the USP Dissolution Test
  76. Modified p-values for one-sided testing in restricted parameter spaces
  77. Modified p-Value of Two-Sided Test for Normal Distribution with Restricted Parameter Space
  78. Improved confidence estimators for confidence sets of location parameters
  79. Improved estimation of accuracy in simple hypothesis versus simple alternative testing
  80. Improved confidence estimators for the usual one-sided confidence intervals for the ratio of two normal variances
  81. Admissibility of Confidence Estimators in the Regression Model
  82. The problem of low counts in a signal plus noise model
  83. Brown's paradox in the estimated confidence approach
  84. Estimated confidence under ancillary statistic everywhere-valid constraint
  85. Admissibility of the constant-coverage probability estimator for estimating the coverage function of certain confidence interval